جميع البطاقات

محتوى البطاقات متوفر باللغة 中文 وEnglish و日本語؛ وتُعرض النسخة الإنجليزية لهذه اللغة.

LUNGS & BREATHINGLow-dose CT: who shouldand shouldn’t1USPSTF 2021: aged 50–80, ≥20 pack-years,current smoker or quit <15 years → yearly2NLST: in heavy smokers, LDCT cut lung-cancermortality by 20% (relative)3The cost: 24% of scans positive, 96% of thoseturn out not to be cancer4Overdiagnosis is about 18% of detected cancers5Never-smokers without family history: norandomised trial shows lower mortality6LDCT uses no contrast — no direct effect onkidney functionTaiwan’s public programme also covers family history — checkthe Health Promotion Administration for criteria. Quittingbeats any screening.BBeyond CKDbeyondckd.com/ar/cards/who-should-get-ldctSources: NLST · USPSTF 2021 · 2026-10-17Compiled from public clinical guidelines · General education, not individual medical advice
LINE Facebook

Lungs & breathing

Low-dose CT: who should and shouldn’t

Annual LDCT lung-cancer screening for everyone? The evidence only supports high-risk groups.

  1. 1USPSTF 2021: aged 50–80, ≥20 pack-years, current smoker or quit <15 years → yearly
  2. 2NLST: in heavy smokers, LDCT cut lung-cancer mortality by 20% (relative)
  3. 3The cost: 24% of scans positive, 96% of those turn out not to be cancer
  4. 4Overdiagnosis is about 18% of detected cancers
  5. 5Never-smokers without family history: no randomised trial shows lower mortality
  6. 6LDCT uses no contrast — no direct effect on kidney function

Taiwan’s public programme also covers family history — check the Health Promotion Administration for criteria. Quitting beats any screening.

نص المنشور (جاهز للّصق)

Annual LDCT lung-cancer screening for everyone? The evidence only supports high-risk groups.

1. USPSTF 2021: aged 50–80, ≥20 pack-years, current smoker or quit <15 years → yearly
2. NLST: in heavy smokers, LDCT cut lung-cancer mortality by 20% (relative)
3. The cost: 24% of scans positive, 96% of those turn out not to be cancer
4. Overdiagnosis is about 18% of detected cancers
5. Never-smokers without family history: no randomised trial shows lower mortality
6. LDCT uses no contrast — no direct effect on kidney function

Taiwan’s public programme also covers family history — check the Health Promotion Administration for criteria. Quitting beats any screening.

المصادر: NLST — Reduced lung-cancer mortality with LDCT — N Engl J Med 2011; USPSTF 2021 — Screening for lung cancer
تاريخ التحقّق: 2026-10-17

تُعدّ البطاقات والنصوص مواد تثقيف صحي عام مُنظَّمة بالاستناد إلى إرشادات سريرية علنية، وليست نصيحة طبية فردية، ولا تغني عن تقييم الطبيب أو الصيدلاني أو اختصاصي التغذية. يُرجى الإبقاء على المصادر وهذا البيان عند المشاركة؛ وأي تحديث للمحتوى يكون اعتمادُه على هذه الصفحة.
https://beyondckd.com/ar/cards/who-should-get-ldct
نص مقطع فيديو قصير مدته 60 ثانية

تقسيم المشاهد والتعليق الصوتي. عمودي 9:16، يُفضَّل وضع الترجمة في الثلث السفلي من الشاشة؛ كل جملة في التعليق الصوتي تقابلها المصادر في العمود الأيسر.

ثانيةالمشهدالتعليق الصوتي
0–5CT scannerShould you get a low-dose CT every year?
5–25USPSTF criteriaUS guidance: aged 50 to 80, 20 pack-years, still smoking or quit under 15 years ago — once a year.
25–4524% positive → 96% falseNLST cut lung-cancer deaths by 20%, but a quarter of scans were positive and 96% of those were not cancer.
45–60Never-smoker question markFor never-smokers, no randomised trial shows yearly LDCT helps. Family history? Talk to your doctor.

المصادر (كل نقطة على البطاقة يمكن إسنادها لمصدر)

تاريخ التحقّق: 2026-10-17